IPSEN PHARMA has a total of 110 patent applications. Its first patent ever was published in 1996. It filed its patents most often in EPO (European Patent Office), Czechia and Hong Kong. Its main competitors in its focus markets pharmaceuticals, biotechnology and organic fine chemistry are AETERNA ZENTARIS GMBH, CONSEILS DE RECH S ET D APLICA and CORNERSTONE THERAPEUTICS INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 82 | |
#2 | Czechia | 7 | |
#3 | Hong Kong | 6 | |
#4 | China | 5 | |
#5 | Hungary | 4 | |
#6 | Brazil | 1 | |
#7 | France | 1 | |
#8 | Iceland | 1 | |
#9 | Taiwan | 1 | |
#10 | United States | 1 | |
#11 | WIPO (World Intellectual Property Organization) | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Organic fine chemistry | |
#4 | Medical technology | |
#5 | Macromolecular chemistry and polymers | |
#6 | Chemical engineering | |
#7 | Environmental technology | |
#8 | Measurement |
# | Name | Total Patents |
---|---|---|
#1 | Dong Zheng Xin | 39 |
#2 | Cherif-Cheikh Roland | 14 |
#3 | Moreau Jacques-Pierre | 13 |
#4 | Bigg Dennis | 12 |
#5 | Chabrier De Lassauniere Pierre-Etienne | 10 |
#6 | Thurieau Christophe | 9 |
#7 | Prevost Gregoire | 9 |
#8 | Liberatore Anne-Marie | 8 |
#9 | Shen Yeelana | 8 |
#10 | Harnett Jeremiah | 6 |
Publication | Filing date | Title |
---|---|---|
CN107735127A | Injector assembly | |
CN103080128A | Reversed phase HPLC purification of a GLP-1 analogue | |
EP2168983A1 | New octapeptide compounds and their therapeutic use | |
EP2106788A1 | Liquid and freeze dried formulations | |
EP2003967A2 | Use of somatostatin agonists to treat medullary thyroid carcinoma | |
EP2012809A2 | Use of a ghrelin agonist to improve the catabolic effects of glucocorticoid treatment | |
EP1915168A2 | Ligands of melanocortin receptors | |
EP1722813A1 | Cosmetic or therapeutic use of botulinum toxin for preventing hair growth |